Back to Gene
CTNS gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

CTNS gene

The CTNS gene provides instructions for making the protein cystinosin, which is essential for transporting the amino acid cystine out of cellular lysosomes.

Normal Function

The CTNS gene provides instructions for making a protein called cystinosin. This protein is located in the membrane of lysosomes, which are compartments in the cell that digest and recycle materials. Proteins digested inside lysosomes are broken down into smaller building blocks, called amino acids. The amino acids are then moved out of lysosomes by transport proteins. Cystinosin is a transport protein that specifically moves the amino acid cystine out of the lysosome.

Health Conditions Related to Genetic Changes

Cystinosis

More than 80 different mutations that are responsible for causing cystinosis have been identified in the CTNS gene. The most common mutation is a deletion of a large part of the CTNS gene (sometimes referred to as the 57-kb deletion), resulting in the complete loss of cystinosin. This deletion is responsible for approximately 50 percent of cystinosis cases in people of European descent.

Other mutations result in the production of an abnormally short protein that cannot carry out its normal transport function. Mutations that change very small regions of the CTNS gene may allow the transporter protein to retain some of its usual activity, resulting in a milder form of cystinosis.

Genomic Location

The CTNS gene is found on chromosome 17.

Frequently Asked Questions

kidney transplant restores kidney function, but cystine continues to accumulate in other tissues. Post‑transplant patients must continue cysteamine therapy and regular eye and bone monitoring to prevent systemic complications. The transplant does not eliminate the underlying genetic defect.
Infants with cystinosis often develop a characteristic “blue‑eye” appearance due to corneal cystine crystals, and may show poor weight gain, vomiting, or dehydration from impaired kidney function. Early eye exams and urine tests for cystine can catch the disease before significant kidney damage occurs.
Cysteamine reduces cystine accumulation in lysosomes by forming a cysteine–cysteamine mixed disulfide that can exit the lysosome. Daily oral or topical cysteamine (eye drops) slows kidney decline, improves growth, and reduces eye complications. Regular monitoring of cystine levels ensures the dose is effective.
definitive diagnosis is made by measuring cystine levels in a skin biopsy or leukocytes, and by sequencing the CTNS gene to identify mutations such as the common 57‑kb deletion. A positive result guides treatment and family counseling.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab